| 750628 |
ONCOTARGETS AND THERAPY |
TP53 Co-Mutational Features and NGS-Calibrated Immunohistochemistry Threshold in Gastric Cancer |
2021-10-01 |
10.2147/ott.s321949 |
Yu Ruili, Sun Tingyi, Zhang Xianwei, Li Zhen, Xu Yang, Liu Kaihua, Shi Yuqian, Wu Xue, Shao Yang, Kong Lingfei |
| 750627 |
ONCOTARGETS AND THERAPY |
ALK Rearrangement in Small-Cell Lung Cancer and Durable Response to Alectinib: A Case Report |
2021-10-01 |
10.2147/ott.s323700 |
Sun Ning, Zhuang Yan, Zhang Junling, Chen Shiqing, Dai Yuwen, Guo Renhong |
| 750626 |
ONCOTARGETS AND THERAPY |
Comparative Transcriptome Provides a Systematic Perspective on Epstein–Barr Virus-Associated Gastric Carcinoma Cell Lines |
2021-10-01 |
10.2147/ott.s332513 |
Huang Jun-Ting, Chen Jian-Ning, Bi Yuan-Hua, Gong Li-Ping, Zhang Jing-Yue, Du Yu, Shao Chun-Kui |
| 750625 |
ONCOTARGETS AND THERAPY |
Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib |
2021-10-01 |
10.2147/ott.s272208 |
Yu James, Mahipal Amit, Kim Richard |
| 750624 |
ONCOTARGETS AND THERAPY |
Interaction of Gut Microbiome and Host microRNAs with the Occurrence of Colorectal and Breast Cancer and Their Impact on Patient Immunity |
2021-10-01 |
10.2147/ott.s329383 |
De Silva Sumadee, Tennekoon Kamani Hemamala, Karunanayake Eric Hamilton |
| 750623 |
ONCOTARGETS AND THERAPY |
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum] |
2021-10-01 |
10.2147/ott.s343977 |
LeVee Alexis, Lin Ching Ying, Posadas Edwin, Figlin Robert, Bhowmick Neil A, Di Vizio Dolores, Ellis Leigh, Rosser Charles J, Freeman Michael R, Theodorescu Dan, Freedland Stephen J, Gong Jun |
| 750622 |
ONCOTARGETS AND THERAPY |
ITPKA1 Promotes Growth, Migration and Invasion of Renal Cell Carcinoma via Activation of mTOR Signaling Pathway [Corrigendum] |
2021-10-01 |
10.2147/ott.s342980 |
Zhu Xiang, Xu An, Zhang Yang, Huo Nan, Cong Rui, Ma Luyuan, Chu Zhong, Tang Zhi, Kang Xiaofeng, Xian Shaozhong, Xu Xiaojie |
| 750621 |
ONCOTARGETS AND THERAPY |
Clinical Application of Tumor Vascular Disrupting Therapy: A Systematic Review and Meta-Analysis |
2021-10-01 |
10.2147/ott.s321658 |
Tsang Wen, Gan Lu, Zhang Zhikun, Li Tong, Luo Yiqun, Zhong Liping, Huang Yong |
| 750620 |
ONCOTARGETS AND THERAPY |
Feasibility and Safety of Neoadjuvant Alectinib in Pulmonary Invasive Mucinous Adenocarcinoma with ALK Rearrangement: Case Report and Literature Review |
2021-10-01 |
10.2147/ott.s334213 |
Gu Rumeng, Shi Ziling, Duan Ting, Song Meijun |
| 750619 |
ONCOTARGETS AND THERAPY |
Serum Reactive Oxygen Species Modulator 1 as a Novel Predictive Biomarker for Resected Lung Adenocarcinoma: A Retrospective Pilot Study |
2021-10-01 |
10.2147/ott.s336399 |
Chang Boksoon, Hwang In Kyung, Lee Seung Hyeun |
